2.50
HDL Handle:
http://hdl.handle.net/10033/242297
Title:
Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies.
Authors:
Hoenicke, Lisa; Zender, Lars
Abstract:
Cellular senescence, a state of stable growth arrest, can occur in response to various stress stimuli such as telomere shortening, treatment with chemotherapeutic drugs or the aberrant activation of oncogenes. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it has become clear that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Recent work from our laboratory showed that premalignant, senescent hepatocytes are recognized and cleared through an antigen-specific immune response and that this immune response, designated as 'senescence surveillance' is crucial for tumor suppression in the liver [(Kang,T.W. et al. (2011) Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature, 479, 547-551]. It is an emerging concept that immune responses against senescent cells have a broader biological significance in cancer- as well as non-cancer pathologies and current data suggest that distinct immune responses are engaged to clear senescent cells in different disease settings. In this review article, we will discuss different examples how immune responses against senescent cells are involved to restrict disease progression in cancer- and non-cancer pathologies.
Affiliation:
Helmholtz Centre for Infection Research, Braunschweig, Germany.
Citation:
Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies. 2012, 33 (6):1123-6 Carcinogenesis
Journal:
Carcinogenesis
Issue Date:
Jun-2012
URI:
http://hdl.handle.net/10033/242297
DOI:
10.1093/carcin/bgs124
PubMed ID:
22470164
Type:
Article
Language:
en
ISSN:
1460-2180
Appears in Collections:
Publications of NG Chronische Infektionen und Krebs CHIK

Full metadata record

DC FieldValueLanguage
dc.contributor.authorHoenicke, Lisaen_GB
dc.contributor.authorZender, Larsen_GB
dc.date.accessioned2012-09-10T13:45:39Z-
dc.date.available2012-09-10T13:45:39Z-
dc.date.issued2012-06-
dc.identifier.citationImmune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies. 2012, 33 (6):1123-6 Carcinogenesisen_GB
dc.identifier.issn1460-2180-
dc.identifier.pmid22470164-
dc.identifier.doi10.1093/carcin/bgs124-
dc.identifier.urihttp://hdl.handle.net/10033/242297-
dc.description.abstractCellular senescence, a state of stable growth arrest, can occur in response to various stress stimuli such as telomere shortening, treatment with chemotherapeutic drugs or the aberrant activation of oncogenes. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it has become clear that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Recent work from our laboratory showed that premalignant, senescent hepatocytes are recognized and cleared through an antigen-specific immune response and that this immune response, designated as 'senescence surveillance' is crucial for tumor suppression in the liver [(Kang,T.W. et al. (2011) Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature, 479, 547-551]. It is an emerging concept that immune responses against senescent cells have a broader biological significance in cancer- as well as non-cancer pathologies and current data suggest that distinct immune responses are engaged to clear senescent cells in different disease settings. In this review article, we will discuss different examples how immune responses against senescent cells are involved to restrict disease progression in cancer- and non-cancer pathologies.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Carcinogenesisen_GB
dc.titleImmune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies.en
dc.typeArticleen
dc.contributor.departmentHelmholtz Centre for Infection Research, Braunschweig, Germany.en_GB
dc.identifier.journalCarcinogenesisen_GB

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.